Emergence of ART technologies will help global fertility services market to surpass $20 billion by 2020

Renewable energy


This market research report includes a detailed segmentation of the global fertility services market by treatment type (infertility drugs and ART) and by underlying cause (male infertility and female infertility). It also outlines the market shares of key regions such as the Americas, APAC, and EMEA. The key vendors analyzed in this report are Care Fertility, CooperSurgical, Ferring Pharmaceuticals, Merck, Monash IVF, and Vitrolife.

Technavio’s market research analysts estimate the global fertility services market to grow at a CAGR of 9% between 2016 and 2020. The increase in fertility complications is one of the major drivers for the growth of the market.  Advances in technology have led to the development of innovative fertility solutions such as IVF, ICSI, IUI, and other assisted reproductive technology (ART) services. EMEA is the leading region in the global fertility services market, owing to increased demand for infertility treatments and the increase in sedentary lifestyles in the region.

The new market research report from Technavio provides a breakdown and analysis of the fertility services segments by technology.

“Of late, the surge in global demand for fertility services has resulted in the growing number of fertility clinics across the globe. This rise in the number of fertility clinics has made fertility services accessible to many couples with infertility complications. Koreover, the vendors are conducting more innovative research activities to gain a clear understanding of several aspects related to infertility. This will help fertility clinics provide better support and treatment for infertility, which in turn will increase the usage of fertility services in the coming years,” says Barath Palada, Lead Analyst, Healthcare & Lifesciences, Technavio Research.

Female infertility is a very common problem in about 10% of women in the age range of 15-44 years. As per the NICE guidelines, female infertility is the inability of a woman of reproductive age to conceive after one year of unprotected vaginal intercourse. Ovulation disorders, submucosal fibroids, pelvic inflammatory disease, and endometriosis are few of the factors that can cause infertility in women.

The leading vendors in the global fertility services market include Care Fertility, CooperSurgical, Ferring Pharmaceuticals, Merck, Monash IVF, and Vitrolife. This market is highly competitive, which is propelled by M&A and investment in R&D activities for the development of novel products. Moreover, a lot of new players are also expected to foray into the market during the forecast period because of the high revenue-generating potential of the market, which will further increase the competition in the market. Thus, manufacturers are adopting strategies such as acquiring local distributors and establishing alliances with fertility centers or clinics to enhance their market share.

A more detailed analysis is available in the Technavio report, Global Fertility Services Market 2016-2020.

We can customize reports by other regions and specific segments upon request.

Other related reports: